Epstein-Barr Virus Mucocutaneous Colonic Ulcer in an Immunocompetent Patient. by Magdaleno, Travis, MD et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Medicine
Epstein-Barr Virus Mucocutaneous Colonic Ulcer
in an Immunocompetent Patient.
Travis Magdaleno MD
Lehigh Valley Health Network, travis.magdaleno@lvhn.org
Eric Nellis MD
Lehigh Valley Health Network, eric.nellis@lvhn.org
Paola Blanco MD
Lehigh Valley Health Network, Paola_G.Blanco@lvhn.org
Follow this and additional works at: https://scholarlyworks.lvhn.org/medicine
Part of the Gastroenterology Commons, and the Medical Sciences Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Magdaleno, T. Nellis, E. Blanco, P. (2017, October 13). Epstein-Barr Virus Mucocutaneous Colonic Ulcer in an Immunocompetent Patient.
Poster Presented at: The American College of Gastroenterology, Orlando, FL.
© 2017 Lehigh Valley Health Network
 •  Epstein Barr Virus (EBV) positive mucocutaneous 
ulcers (MCU) were first described in 2010 in 
immunosuppressed patients occurring in the 
mouth, skin, and GI tract1
 •  Lesions are described as shallow, sharply 
circumscribed mucosal or cutaneous ulcers2
   −  Histology notes polymorphous infiltrates of 
lymphocytes and immunoblasts with EBER1-positive 
features2
 •  Typically EBVMCU are treated conservatively, and 
resolve with reversal of immunosuppression1,2,3
 •  Some reports have described an association with 
disseminated Hodgkin’s Lymphoma and diffuse 
large B-cell lymphomas (DLBCL)2,3
 •  We report a case of an EBVMCU discovered in an 
immunocompentent patient superimposed with 
acute campylobacter colitis with serologic evidence 
of recent EBV infectious mononucleosis
Epstein Barr Virus Mucocutaneous Colonic Ulcer in an
Immunocompetent Patient 
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 •  A 47 year-old male with no PMH presented with 
a 1-month history of bloody diarrhea with a 
recent development of pharyngitis with flu-like 
symptoms 1 week prior
 •  Physical exam noted pharyngeal erythema, 
symmetrical bilateral cervical lymphadenopathy, 
and diffuse abdominal tenderness
 •  Admission labs were significant for a normal 
hemoglobin, leukocytosis with a lymphocytic 
predominance, and LFT abnormalities
 •  CT of his abdomen and pelvis revealed 
circumferential rectal wall thickening with 
stranding in the setting of diffuse abdominal 
lymphadenopathy, splenomegaly, and multiple 
hepatic lesions. Radiographically concerning for 
malignancy
 •  As of April 2016, 51 cases of EBVMCU has been described in the literature2
   −  5 cases described colonic involvement
 •  All reports have been associated with immunosuppression by either 
medication or age-related immunosenescence in patients over the age of 602
 •  The majority of cases were self-limited and resolved with reversal of 
immunosuppression. Rare cases were treated with Rituximab or with surgical 
resection. One case was treated with chemotherapy (R-CHOP) however all 
cases reported complete remission3
 •  Described here is a rare case in which a colonic EBVMCU was discovered 
within a young otherwise healthy male during acute campylobacter colitis 
with serologic evidence of recent infectious mononucleosis 
 •  Although in previous literature, EBVMCU were reported to fall within the 
spectrum of EBV-associated proliferative disorders, the 2016 WHO update 
of the classification of lymphoid neoplasms have recognized EBVMCU as a 
separate entity from EBV positive DLBCL due to their observed self-limited 
growth and response to conservative management2,4
DISCUSSION
 •  Serum AFP, CEA, CA 19-9 were within normal 
limits. HIV screen were negative. Fecal 
calprotectin was noted to be over 830ug/g
 •  Further evaluation with a hepatic MRI noted 
liver cysts. Stool cultures were positive for 
Campylobacter
 •  He was treated with azithromycin however 
symptoms persisted
 •  Colonoscopy revealed several clean-based ulcers 
within the rectum and sigmoid colon (Figure 1)
 •  Biopsies were positive for EBVMCU (Figure 2). 
Serum EBV serologies indicated recent EBV 
infection
 •  Symptoms eventually improved and patient 
was discharged in stable condition with 
recommended outpatient follow-up 
1Department of Medicine, 2Department of Gastroenterology, Lehigh Valley Health Network, Allentown, Pennsylvania
Travis Magdaleno DO1, Eric Nellis MD2, and Paola Blanco MD2
INTRODUCTION
CASE REPORT
Figure 1: Colonoscopy acquired images depicting several clean based rectal ulcers Figure 2: (Left) H&E stain of rectal ulcer noting colonic mucosa with dense 
lymphoplasmacyctic infiltrate. (Right) EBV in situ hybridization indicating presence of 
EBV DNA within the nuclei of infected cells. 
